230 related articles for article (PubMed ID: 26639895)
21. Selective activation of the prostaglandin E2 receptor subtype EP2 or EP4 leads to inhibition of platelet aggregation.
Kuriyama S; Kashiwagi H; Yuhki K; Kojima F; Yamada T; Fujino T; Hara A; Takayama K; Maruyama T; Yoshida A; Narumiya S; Ushikubi F
Thromb Haemost; 2010 Oct; 104(4):796-803. PubMed ID: 20664890
[TBL] [Abstract][Full Text] [Related]
22. Prostaglandin E2-induced modification of tetrodotoxin-resistant Na+ currents involves activation of both EP2 and EP4 receptors in neonatal rat nodose ganglion neurones.
Matsumoto S; Ikeda M; Yoshida S; Tanimoto T; Takeda M; Nasu M
Br J Pharmacol; 2005 Jun; 145(4):503-13. PubMed ID: 15821755
[TBL] [Abstract][Full Text] [Related]
23. Possible involvement of brain prostaglandin E2 and prostanoid EP3 receptors in prostaglandin E2 glycerol ester-induced activation of central sympathetic outflow in the rat.
Shimizu T; Tanaka K; Nakamura K; Taniuchi K; Yawata T; Higashi Y; Ueba T; Dimitriadis F; Shimizu S; Yokotani K; Saito M
Neuropharmacology; 2014 Jul; 82():19-27. PubMed ID: 24657150
[TBL] [Abstract][Full Text] [Related]
24. Prostaglandin E2 prevents hyperosmolar-induced human mast cell activation through prostanoid receptors EP2 and EP4.
Torres-Atencio I; Ainsua-Enrich E; de Mora F; Picado C; Martín M
PLoS One; 2014; 9(10):e110870. PubMed ID: 25329458
[TBL] [Abstract][Full Text] [Related]
25. The EP1/EP3 receptor agonist 17-pt-PGE
Theiler A; Konya V; Pasterk L; Maric J; Bärnthaler T; Lanz I; Platzer W; Schuligoi R; Heinemann A
Vascul Pharmacol; 2016 Dec; 87():180-189. PubMed ID: 27664754
[TBL] [Abstract][Full Text] [Related]
26. Modulation of host natural killer cell functions in breast cancer via prostaglandin E2 receptors EP2 and EP4.
Holt DM; Ma X; Kundu N; Collin PD; Fulton AM
J Immunother; 2012; 35(2):179-88. PubMed ID: 22306906
[TBL] [Abstract][Full Text] [Related]
27. Prostaglandin E
Nagano T; Tsuda N; Fujimura K; Ikezawa Y; Higashi Y; Kimura SH
J Neuroimmunol; 2021 Dec; 361():577724. PubMed ID: 34610503
[TBL] [Abstract][Full Text] [Related]
28. Dual Blockade of EP2 and EP4 Signaling is Required for Optimal Immune Activation and Antitumor Activity Against Prostaglandin-Expressing Tumors.
Francica BJ; Holtz A; Lopez J; Freund D; Chen A; Wang D; Powell D; Kipper F; Panigrahy D; Dubois RN; Whiting CC; Prasit P; Dubensky TW
Cancer Res Commun; 2023 Aug; 3(8):1486-1500. PubMed ID: 37559947
[TBL] [Abstract][Full Text] [Related]
29. Prostaglandin E2 induces apoptosis in cultured rat microglia.
Nagano T; Kimura SH; Takemura M
Brain Res; 2014 Jun; 1568():1-9. PubMed ID: 24845544
[TBL] [Abstract][Full Text] [Related]
30. Anti-inflammatory effects of PGE2 in the lung: role of the EP4 receptor subtype.
Birrell MA; Maher SA; Dekkak B; Jones V; Wong S; Brook P; Belvisi MG
Thorax; 2015 Aug; 70(8):740-7. PubMed ID: 25939749
[TBL] [Abstract][Full Text] [Related]
31. 15-Keto-PGE
Endo S; Suganami A; Fukushima K; Senoo K; Araki Y; Regan JW; Mashimo M; Tamura Y; Fujino H
J Biol Chem; 2020 Sep; 295(38):13338-13352. PubMed ID: 32727851
[TBL] [Abstract][Full Text] [Related]
32. Prostaglandin E2 promotes human CD34+ cells homing through EP2 and EP4 in vitro.
Wang Y; Lai S; Tang J; Feng C; Liu F; Su C; Zou W; Chen H; Xu D
Mol Med Rep; 2017 Jul; 16(1):639-646. PubMed ID: 28560401
[TBL] [Abstract][Full Text] [Related]
33. Intact prostaglandin signaling through EP2 and EP4 receptors in stromal progenitor cells is required for normal development of the renal cortex in mice.
Fuchs MAA; Schrankl J; Leupold C; Wagner C; Kurtz A; Broeker KA
Am J Physiol Renal Physiol; 2022 Mar; 322(3):F295-F307. PubMed ID: 35037469
[TBL] [Abstract][Full Text] [Related]
34. Tailored PGE2 Immunomodulation of moDCs by Nano-Encapsulated EP2/EP4 Antagonists.
Bödder J; Kok LM; Fauerbach JA; Flórez-Grau G; de Vries IJM
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674907
[TBL] [Abstract][Full Text] [Related]
35. The cyclooxygenase-2-prostaglandin E2 pathway maintains senescence of chronic obstructive pulmonary disease fibroblasts.
Dagouassat M; Gagliolo JM; Chrusciel S; Bourin MC; Duprez C; Caramelle P; Boyer L; Hue S; Stern JB; Validire P; Longrois D; Norel X; Dubois-Randé JL; Le Gouvello S; Adnot S; Boczkowski J
Am J Respir Crit Care Med; 2013 Apr; 187(7):703-14. PubMed ID: 23328527
[TBL] [Abstract][Full Text] [Related]
36. The anti-inflammatory effects of PGE
Gill SK; Yao Y; Kay LJ; Bewley MA; Marriott HM; Peachell PT
Br J Pharmacol; 2016 Nov; 173(21):3099-3109. PubMed ID: 27460634
[TBL] [Abstract][Full Text] [Related]
37. Effects of prostaglandin E2 on gene expression in primary osteoblastic cells from prostaglandin receptor knockout mice.
Li X; Pilbeam CC; Pan L; Breyer RM; Raisz LG
Bone; 2002 Apr; 30(4):567-73. PubMed ID: 11934647
[TBL] [Abstract][Full Text] [Related]
38. Upregulation of the S1P
Filipenko I; Schwalm S; Reali L; Pfeilschifter J; Fabbro D; Huwiler A; Zangemeister-Wittke U
Biochim Biophys Acta; 2016 Nov; 1861(11):1840-1851. PubMed ID: 27616330
[TBL] [Abstract][Full Text] [Related]
39. Binary regulation of interleukin (IL)-6 production by EP1 and EP2/EP4 subtypes of PGE2 receptors in IL-1beta-stimulated human gingival fibroblasts.
Noguchi K; Shitashige M; Endo H; Kondo H; Ishikawa I
J Periodontal Res; 2002 Feb; 37(1):29-36. PubMed ID: 11842936
[TBL] [Abstract][Full Text] [Related]
40. Prostaglandin E2 represses interleukin 1 beta-induced inflammatory mediator output from pregnant human myometrial cells through the EP2 and EP4 receptors.
Mosher AA; Rainey KJ; Giembycz MA; Wood S; Slater DM
Biol Reprod; 2012 Jul; 87(1):7, 1-10. PubMed ID: 22517618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
